Summary
36 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $6.06M against $1.30M.
- The price moves less than the market (beta 0.61).
What to watch
- Revenue fell by 44% a year over the last 3 years.
- The company made a loss over the last 12 months.
- It passes only 2 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 24% a year over 5 years. Over the last 3 years it fell by 44% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $3.93M.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 6
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $1,238 is 1,364,288% above today's price. 75% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Contract Manufacturing 50%
- Cigarettes 37%
- Filtered Cigars 12%
- Other Tobacco Products 1.3%
By region
The company reports no revenue by region.
Contract Manufacturing brings in 50% of revenue.
Segments in detail